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Abstract
Scurfy mice display the most severe form of multi-organ inflammation due to total lack of the
CD4+Foxp3+ regulatory T cells (Treg) resulted from a mutation of the X-linked transcription factor
Foxp3. A large repertoire of Treg-suppressible, inflammation-inducing T cells was demonstrated by
adoptive transfer experiments using Rag1-/- mice as recipients and by prolongation of lifespan
through breeding with Faslpr/lpr mutant. Inflammation in the ear, eyes, skin, tail, salivary glands, lungs,
stomach, pancreas, liver, small intestine, colon, skeletal muscle, and accessory reproductive organs
are identified. Genetic and cellular regulations of specific organ inflammation are described. Sf mice
may be useful for the identification of organ-specific antigens and Treg capable of suppressing
inflammation in an organ-specific manner. Sf mice are also useful to determine the important
inflammation process at the checkpoint after Treg regulation using genetic analysis through
breeding.
Review
Thymic selection imparts T cell subsets with distinct func-
tions and specific antigenic markers. In the thymus, the
CD4+ T cell compartment contains a Foxp3- population
(termed conventional T cells or Tconv) that when exits to
the periphery will respond to antigenic stimulation and a
Foxp3+ population (regulatory T cells or Treg) that when
exits to the periphery will suppress immune responses
[reviewed in [1-3]]. Although negative selection elimi-
nates the high-affinity T cells that react with self antigens,
T cells reactive with self antigens with low to moderate
affinity may escape negative selection and exit to the
periphery where they may become auto-reactive under
appropriate conditions [4,5]. The presence of Treg is nec-
essary to suppress this response to maintain peripheral
tolerance. Early works using day-3 thymectomy or anti-
CD25 antibody treatment have implicated Treg presence
[6,7], but the most convincing and definitive evidence for
Treg came from the genetic studies of Scurfy (Sf) mice and
IPEX patients, both display fatal multi-organ inflamma-
tion caused by mutations in the transcription factor Foxp3
[8,9]. Foxp3 is absolutely required for the Treg generation
in the thymus and Treg maintenance in the periphery. In
this regard, the demonstration of inducible Treg from
naïve CD4+CD25-Foxp3- T cells in the periphery implies
that Sf mice and IPEX patients must also lack inducible
Treg [10]. Inducible Treg may be more important for the
regulation of immune response to foreign antigens or for-
eign antigens steadily associated with the host. Thus,
Foxp3 expression is required lifelong for the maintenance
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of tolerance [11]. Foxp3 expression defect may result in
spontaneous response to both self antigens and foreign
antigens steadily represented in the host.
The overall Treg expression in the periphery is affected by
factors that participate in the Treg generation in the thy-
mus and by factors that maintain Treg expression in the
periphery. In addition to Foxp3, thymic Treg generation
depends on high-affinity IL-2 signaling [12]. In the
absence of IL-2 or IL-2R, thymic Treg generation is
reduced but IL-7 signaling can partially compensate this
defect [12]. Another study using Foxp3-GFP knock-in
mice also favors the interpretation that IL-2 is not indis-
pensable for the thymic Foxp3+  Treg generation [13].
Naïve CD4+Foxp3- T cells in the periphery could be con-
verted to functional CD4+Foxp3+ T cells when activated
through TCR and in the presence of IL-2 and TGF-1 [10].
Peripheral Treg are maintained to a great extent by the
high affinity IL-2 and TGF-1 signaling pathways [14-16].
In the periphery, IL-2 defect can be compensated to a sig-
nificant extent by the IL-15/IL-15R signaling pathway but
the requirement of TGF-1 is indispensable [10,12,17].
Many factors that regulate Treg development and homeos-
tasis also regulate Tconv cells. Because of this complicated
etiology and regulation, Treg expression in different
mutant strains varied and its effect on peripheral tolerance
results in varying manifestation of multi-organ inflamma-
tion. We will focus on the multi-organ inflammation
associated with Il2-/- and Sf mice in the B6 genetic back-
ground because they have been extensively studied.
Spontaneous multi-organ inflammation is a characteristic
of Treg deficiency and Sf mice provide the best source to
study such process. A contentious issue is whether the
multi-organ inflammation responses are the results of
activation of organ-specific auto-reactive T cells. Critically
speaking, these spontaneous inflammation responses
cannot be considered autoimmune without the identifica-
tion of the target antigens and their organ-specific associ-
ation. Perhaps the best example that Treg control auto-
immune response is the gastritis induced by day-3-
thymectomy that activates both T and B cell responses
against the H+/K+-ATPase of stomach parietal cells
[18,19]. In experimental autoimmune prostatitis and
oocytitis, specific responses against EAPA and MATER
organ antigens have been implicated [20,21]. Antibodies
reactive against a mitochondrial antigen associated with
cholangitis have been demonstrated in Sf mice [22].
Because Treg controls immune responses to both self and
foreign antigens, it is likely that the multi-organ inflam-
mation is the result of loss of tolerance to self antigens as
well as foreign antigens that are more often associated
with particular organs in the host including the steady
presence of antigens from the environment, food, bed-
ding, and microbiota [23].
Sf mice display the most severe form of spontaneous
multi-organ inflammation disease but their multi-organ
inflammation is restricted to a few. Sf mice die around
24–28 days old with severe inflammation in the ear, con-
junctiva, skin, lungs, liver and tail. [24]. Common
autoimmune diseases such as thyroiditis, diabetes,
encephalomyelitis, arthritis, glomerulonephritis and
inflammation in the oral and gastrointestinal tracts are
not observed [24,25]. Two approaches were used to deter-
mine if early death or pre-weaning condition prevented
the expression of inflammation in these organs. The
lifespan of Sf mice can be prolonged to 8–20 weeks old by
introducing the apoptosis-preventing Faslpr/lpr gene [26].
Surprisingly, additional inflammation was observed only
in colon and accessory reproductive organs. Thus, pre-
weaning condition may not be the only factor that affects
organ-specific expression of inflammation. The second
method is by transferring Sf lymph node cells into Rag1-/-
recipients [25]. This approach not only induced severe
inflammation in the skin, lung and liver but also in sali-
vary gland, stomach, pancreas, small intestine, and colon.
Thus, Sf mice probably contain many inflammation-
inducing T cells capable of inducing inflammation in var-
ious organs. Some of the organs that are not inflamed are
probably caused by factors other than early death or the
absence of inflammation-inducing T cells [25].
For simplicity and clarity purpose, a summary figure (Fig-
ure 1) is used to present the inflammation of various
organs induced under various conditions. In each presen-
tation, leukocyte infiltration is indicated by arrows. Nega-
tive controls totally lack leukocyte infiltration and they are
not presented. Description of each panel is included in the
figure legend.
Skin inflammation
Skin inflammation is the earliest external symptom
observed in Sf mice. The severely inflamed areas are ear,
eyelids, and tail. Conjunctivitis is probably caused by fre-
quent scratching which also worsened inflammation in
areas surrounding the ears and eyes. Adoptive transfer of
Sf lymph node cells into adult Rag1-/- recipients induced
skin inflammation in which eyelids are the first to appear.
In contrast, tail inflammation is minimal if any, suggest-
ing organ development control of tail inflammation. This
is supported by the expression of tail inflammation fol-
lowing adoptive transfer of Sf lymph node cells into
neonate Rag1-/- recipients [25]. Skin inflammation in Sf
mice is strongly associated with Th2 type of immune
response with high serum IgE [27], but the Th2 type
cytokines and IgE expression occurred with simultaneous
increase of Th1 type response. Perhaps the most interest-
ing observation is the lack of skin inflammation in Sf.Il2-/
- mice which are generated by breeding Il2-/- gene into the
Sf mice. Sf.Il2-/- lymph node cells also failed to induce skinJournal of Biomedical Science 2009, 16:20 http://www.jbiomedsci.com/content/16/1/20
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Multi-organ inflammation in Sf mice, Sf.Faslpr/lpr mice, and Rag1-/- recipients of Sf lymph node cells Figure 1
Multi-organ inflammation in Sf mice, Sf.Faslpr/lpr mice, and Rag1-/- recipients of Sf lymph node cells. Each panel 
represents an inflamed target organ. Target organs were indicated by color: Black indicates spontaneous inflammation in Sf 
mice. Green indicates organs of Rag1-/- recipients of intravenous adoptive transfer (Pancreas is obtained from a recipient of 
intraperitoneal transfer). Blue indicates accessory reproductive organs from 10 weeks old Sf.Faslprlpr male that lived beyond 
weaning. Arrows indicate areas of leukocyte infiltration. Magnification is 10× for all except for testis which is 20×.Journal of Biomedical Science 2009, 16:20 http://www.jbiomedsci.com/content/16/1/20
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inflammation upon transfer into Rag1-/- recipients. Thus,
IL-2 is required for the induction of skin inflammation in
the absence of Treg [26].
Inflammation in salivary and lacrimal glands
Sjögren's syndrome is characterized by inflammation in
the salivary glands and lacrimal glands with dry mouth
and dry eyes, respectively. Il2-/- and Il2r-/- mice develop
inflammation in these glands and their ability to produce
saliva upon stimulation with Pilocarpine is impaired [28].
Interestingly, Sf mice do not develop inflammation in
these glands but transfer of Sf lymph node cells into Rag1-
/- recipients induced strong inflammation in the lacrimal
glands and salivary glands and inhibited salivation func-
tion, suggesting the presence of inflammation-inducing T
cells against lacrimal and salivary glands [28]. The sub-
mandibular gland (SMG) is the major mouse saliva-pro-
ducing gland and its development is age-dependent and
sexually dimorphic [29]. The acini of the SMG develop
soon after birth and dominate in the early phase of SMG
development. The granular convoluted tubules (GCT)
develop around 3–4 weeks after birth and the expression
is markedly stronger in male than in female mice. Infiltra-
tion in the salivary glands in Il2-/- mice as well as Rag1-/-
recipients of Sf lymph node cells was observed primarily
in the areas of acini but also noticeable around the GCT
areas, with destruction and disappearance of the acini and
atrophy of GCT [28]. We noticed that the SMG in Sf mice
is not only free from inflammation but also growth-
arrested in that the male-dominant expression of GCT is
inhibited, leaving the organ mostly occupied by the acini.
Several observations indicate that GCT development is
not important for SMG inflammation. First, treatment of
the long-lived Sf.Faslpr/lpr  mice with testosterone fully
restored GCT development but still failed to induce
inflammation in the SMG. Second, SMG inflammation
was observed in Il2-/- mice that also have a greatly reduced
GCT expression (but not as severe as Sf mice). Third, treat-
ment of Sf mice with daily oral application of LPS or
Poly:I/C induced SMG inflammation in the absence of
GCT development [30]. The latter observations suggest
that defect in innate immunity and antigen-presentation
may be involved in the inhibition of inflammation in the
salivary and lacrimal glands in Sf mice.
Lung inflammation
Lung inflammation in Sf mice is characterized by the
severe infiltration of leukocytes around the bronchiole
and alveoli. Both peri-vascular and parenchymal infiltra-
tions were observed. In contrast, lung inflammation was
not observed in Il2-/- mice and breeding Il2-/- into Sf mice
(Sf.Il2-/-) inhibited lung inflammation, a situation remi-
niscent of skin inflammation [26]. A recent study has
demonstrated that lacking IL-10-producing Treg is induc-
tive to skin and colon inflammation [31]. However, a nor-
mal level of IL-10 mRNA expression was observed in the
Treg of Il2-/- mice [13]. Our observation with Sf.Il2-/- mice
that lack Treg also ruled out the possibility that the resid-
ual Treg in Il2-/- mice express IL-10 and that lung inflam-
mation is inhibited due to the presence of such IL-10-
producing Treg.
In contrast to Il2-/- mice, Il2r-/- mice display severe lung
inflammation. Although the reason is unknown at
present, Il2r-/- differs from Il2-/- mice in that they over-
express CD8+ memory T cells that occupy more than 75%
of the total T cell repertoire [32]. It is tempting to specu-
late that these CD8+ T cells are responding to air and envi-
ronmental antigens such as virus that are presented
through class-I antigen processing pathway by the lung
antigen-presenting cells. Whether the over-expressed
CD8+ T cells play a role in lung inflammation remains to
be determined.
Gastritis and small intestine inflammation
Gastritis and small intestine inflammation are neither
observed in Sf mice nor in the Sf.Faslpr/lpr mice that have a
prolonged lifespan beyond weaning. However, they were
induced by transfer of Sf lymph node cells into Rag1-/-
recipients [25]. Moreover, gastritis and small intestine
inflammation were not observed in Il2-/- mice and transfer
of Sf.Il2-/- lymph node cells failed to induce inflammation
in the stomach and small intestine. Thus, adoptive trans-
fer of lymph node cells from Sf and Sf.Faslpr/lpr mice into
Rag1-/- recipients remains the only protocol capable of
inducing gastritis and small intestine inflammation.
Although we observed inflammation around the areas
containing the parietal cells of the stomach, whether this
inflammation includes a component against H+/K+
ATPase, like the case in the day-3 thymectomized Balb/c
mice, is unknown at present.
Liver inflammation and cholangitis
Both Il2-/- and Sf mice develop liver inflammation mani-
fested by peri-vascular infiltration of leukocytes. High tit-
ers of all isotypes against anti-mitochondrial protein
(pyruvate dehydrogenase complex component E2) char-
acteristically associated with cholangitis were identified in
the sera of Sf mice [22]. Leukocytic infiltration was
observed around portal area with damage in the biliary
duct. Livers from Sf mice strongly expressed inflammatory
cytokines including TNF-, IFN-, IL-6, IL-12 and IL-23
[22]. Presence of anti-mitochondrial protein antibodies
were also detected in Il2-/- and Sf.Il2-/- mice but the histol-
ogy and cytokine analyses of liver samples are not com-
pleted. Autoimmune cholangitis was also observed in
Il2R-/- mice that display a remarkable increase in the
CD8+ memory T cells and it was shown that this autoim-
mune disease is, in contrast to colitis, more dependent on
the expression of CD8+ T cells [32,33]. However, this con-Journal of Biomedical Science 2009, 16:20 http://www.jbiomedsci.com/content/16/1/20
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clusion was derived from study of CD4-/-Il2R-/- and CD8-
/-Il2R-/- mice without considering the possibility that
these mice still have class-II and class-I MHC Ag-restricted
T cells independent of the co-receptor expression [33].
Pancreatitis
Although often associated with IPEX patients [9], Type-1
diabetes was neither observed in Sf mice nor in Rag1-/-
recipients of Sf lymph node cells. Sf, Sf.Faslpr/lpr, Sf.Il2-/- or
adult Rag1-/- mice that were intravenously transferred with
Sf lymph node cells developed very mild pancreatitis with
peri-vascular infiltration of leukocytes and occasional
destruction of acini outside the islets. Interestingly, mod-
erate to severe pancreatitis with strong leukocyte infiltra-
tion and severe destruction of acini was observed when Sf
lymph node cells were transferred intraperitoneally into
neonatal or adult Rag1-/- recipients [25]. Introducing Sf
gene into NOD mice or BDC2.5 TCR Tg NOD (BDC2.5 is
a diabetogenic TCR) facilitated diabetes and therefore the
Sf pancreatitis may be one of the contributing factors that
accelerate diabetes [24,34]. Using TCR transgenic SF.OT-II
(OVA323–339-specific, I-Ab-restricted) mice, we showed
that in the absence of Treg, antigen-reactive T cells still
require the presence of appropriate antigens with a rea-
sonable binding activity in order to expand, i.e., OT-II
clonotypic T cells were not expanded due to the absence
of OVA whereas non-clonotypic T cells were expanded by
the host antigens [35]. The mouse study suggests that
Treg-deficiency plays more of a facilitating role in the dis-
ease process so as to impinge diabetes development. As
Type-1 diabetes is often observed in IPEX patients, this
study suggests that the IPEX patients must have naturally
occurring auto-reactive T cells with sufficient binding
activity against the islet components present in their sys-
tem.
Colitis
Sf mice do not develop colitis and this is most likely due
to the weaning condition because Sf.Faslpr/lpr mice that
lived beyond weaning develop colitis and transfer of Sf
lymph node cells into adult Rag1-/- recipients also induced
colitis. Transfer into neonate Rag1-/- recipient induced lit-
tle inflammation in the colon before weaning but severe
colitis rapidly developed within a few days after weaning
[25]. Il2-/- mice develop colitis but only after weaning. It is
likely that the microbiota present in the colon contributes
to the colitis development. Colitis seems to be the easiest
organ inflammation induced by adoptive transfer of effec-
tor T cells. Even T cells expressing a single transduced TCR
often induce colitis and this system has been used to
address the "auto-reactive" repertoire of Treg [36]. It is not
clear why such T cells often selectively induce colitis but
not inflammation in other organs, had they had specifi-
city against a self antigen. The possibility that these TCR
recognize food antigens and colon microbiota has been
raised [37]. Interestingly, GFP-tagged T cells derived from
mice with a Foxp3 allele that directs expression of a non-
functional fusion protein of Foxp3-GFP failed to induce
colitis upon transfer into lymphopenic recipients [38].
Integrin E(CD103)7 is a critical homing and retention
receptor for lymphocytes to travel to and lodged in E-cad-
herin-expressing organs, but CD103-/-CD45RBhigh  cells
have been shown to induce colitis upon transfer [39]. We
generated Sf.CD103-/- mice and they have a prolonged
lifespan of 7–8 weeks old. They develop colitis and their
LN cells were able to transfer colitis to Rag1-/- recipients,
demonstrating the presence CD103-independent mecha-
nism for colitis [40].
Myositis
Sf mice do not develop inflammation in the skeletal mus-
cle but direct injection of Sf lymph node cells into the
limb muscle of Rag1-/- mice induces inflammation not
only in the injected sites but also in the skeletal muscle of
the other limbs in addition to the organ inflammation
normally induced by intravenous transfer [25]. In con-
trast, intravenous transfer of Sf lymph node cells failed to
induce skeletal muscle inflammation. It is possible that
directly injected T cells first induced damage of muscle
cells and the released antigens were recognized by the spe-
cific T cells present in the Sf lymph node cells and
expanded. How these T cells travel through the circulation
to induce inflammation in other limb muscle remains to
be established. Co-transfer of CD25+ Treg with Sf lymph
node cells into limb muscle site inhibited myositis and
multi-organ inflammation (our unpublished observa-
tion). It will be of interest to determine whether these
myositis-inducing T cells recognize any of a number of
self antigens that have been implicated in myositis in
patients [41].
Inflammation in the accessory reproductive organs
Although Sf.Faslpr/lpr  mice have a prolonged lifespan
beyond the adult age, they remain reproductive incompe-
tent with low body weight and under-developed repro-
ductive organs. Gross examination revealed a tremendous
atrophy in the various accessory reproductive organs.
These included coagulation glands/seminal vesicle, prep-
utial glands, epididymis and prostate. Histological exam-
ination confirmed the atrophy of these organs, displayed
as shrunken glands and empty lumens. This was accompa-
nied with a prominent presence of leukocytic infiltrates in
the peri-glandular regions, in the interstitial regions of the
testis, and in the regions containing the interstitial cells of
the Leydig between the seminiferous tubules. Testoster-
one treatment successfully restored the growth of the
accessory reproductive organs of Sf.Faslpr/lpr mice but the
leukocytic infiltrates in the reproductive organs were still
present [30].Journal of Biomedical Science 2009, 16:20 http://www.jbiomedsci.com/content/16/1/20
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Sf mice are useful to study organ inflammation regulation 
post Treg checkpoint
As Sf mice are totally devoid of Treg, they are ideal to study
immune regulation of organ inflammation process inde-
pendent from the generation of Treg, i.e., at stages after
Treg checkpoint. This approach has been used to study
how Treg defect impinges on autoimmune disease in
NOD mice, inflammatory arthritis in K/BxN mice, and
Aire-/- mice. In all cases, an accelerated model of autoim-
mune disease developed, indicating not only a critical
control of Treg in autoimmune-prone condition, but also
a significant presence of Treg control is present in NOD,
K/BxN, and Aire-/- mice [24,34,42]. The study of NOD is
particularly meaningful as IPEX patients often display
type-1 diabetes that is not observed in Sf mice.
Because Treg maintenance requires a normal immune sta-
tus, a number of immuno-regulators such as CD28-/-, Il2-/
-, and Faslpr/lpr mutant genes have been bred into Sf mice to
study its effect on the multi-organ inflammation
response. Introducing CD28-/- inhibited Sf inflammation
and the hyper-production of IL-4 and IL-10 with pro-
longed lifespan, suggesting CD28 is important for the
response of Tconv in Sf mice [43]. However, the effect on
multi-organ inflammation was not addressed in detail
and adoptive transfer experiments were not conducted.
CD28 has long been implicated as critical regulator for IL-
2 production, perhaps in the absence of Treg this require-
ment becomes less obvious. We introduced Il2-/- gene into
Sf mice and observed prolongation of lifespan as well. We
also observed reduction of IL-4 but more interestingly we
observed an increase in CD103 expression on the CD4+ T
cells of Sf mice and this increase was blocked in Sf.Il2-/-
mice, suggesting a requirement of Il2-/- on CD103 expres-
sion on CD4+ inflammation-inducing T cells in Sf mice
[26,40]. Importantly, Il2-/- and Sf.Il2-/- mice do not display
skin and lung inflammation associated with Sf mice, rais-
ing the possibility that CD103 controlled by IL-2 is impor-
tant for skin and lung inflammation in Sf mice [26]. In
this respect, Sf mice are ideal to study various factors that
are known regulators of organ-specific inflammation not
only limited in the areas that control activation of Tconv
cells and their effector functions but also the entire
inflammation process including T cell trafficking, hom-
ing, and retention in the target organs.
Fas (CD95)/FasL (CD178) signaling has been implicated
in Treg effector function, reversed T cell signaling for
expansion, and apoptosis. We Bred Il2-/- and Faslpr/lpr into
Sf mice to address these issues and to determine their rel-
ative contribution to the spontaneous inflammation proc-
ess. IL-2 have been shown to be a critical factor for FasL
induction on T cells for AICD (activation-induced T cell
death) and Il2-/- T cells display low AICD compared with
normal control in vitro, presumably due to limited activa-
tion under the in vitro condition [44,45]. However, T cell
expression level in Sf.Il2-/- and their FasL expression are
higher than Sf mice, indicating the Il2-/- effect on Sf mice
in terms of T cell number and inhibition of inflammation
in skin, lung and gastrointestinal organs is not mediated
through AICD defect or reverse signaling [46]. In addi-
tion, Sf.Faslpr/lpr mice display skin and lung inflammation
and develop colitis after weaning but still have a lifespan
significantly longer than Sf mice. These observations indi-
cate that the primary reason that Fas/FasL interaction pro-
longs the lifespan of Sf mice is by inhibiting target organ
death in the inflamed tissues.
A conundrum we often asked is why do Il2-/- mice have a
pattern of multi-organ inflammation different from that
of Sf mice, i.e., no inflammation in the ear, skin, lung, and
tail [26]. Because Il2-/- mice have residual Treg, this pheno-
type could be caused by difference in organ-specific Treg
that regulate the inflammation in these organs. Some
studies do support the preferential presence of antigen-
specific Treg in the organs and their draining lymph nodes
to be responsible for the maintenance of organ-specific
tolerance [47,48]. In addition, specific cytokine may regu-
late inflammation in an organ-specific manner as it has
been shown that Treg lacking the ability to produce IL-10
failed to inhibit skin inflammation and colitis [31]. How-
ever, these organs remained non-inflamed in Sf.Il2-/- mice
that totally lacked Treg [26]. This resistance maintained
throughout the extended lifespan of Sf.Il2-/- mice, indicat-
ing a control mechanism operating beyond or independ-
ent from the Treg checkpoint [26].
Scurfy mice are useful to study Treg-controlled 
inflammation-inducing T cell repertoire
As discussed above, Sf mice contain inflammation-induc-
ing T cells against more than a dozen of organs and poten-
tially other such cells whose organ inflammation-
inducing power is limited by TCR-independent mecha-
nisms. Importantly, the large repertoire of inflammation-
inducing T cells could be suppressed by the polyclonal
Treg, suggesting the presence of an equally large repertoire
of Treg TCR [25].
Sf mice CD4+ T cell repertoire as determined by V sub-
group distribution failed to detect major differences as
compared with B6 control [49], suggesting Sf mice of B6
background do not randomly expand T cells based on V
expression and this is consistent with the notion that Treg
control polyclonal activation of Tconv cells. However,
within each of the V family of Sf mice, marked change in
TCR spectratype was observed [49]. This change is perva-
sive and stochastic. Similar results were observed with Il2-
/- and Il2r-/- mice and for TCR V family members [49].
By using foreign antigen-specific, MHC-II-restricted, TCR
Tg mice (OT-II versus Sf.OT-II), the antigen requirementJournal of Biomedical Science 2009, 16:20 http://www.jbiomedsci.com/content/16/1/20
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for the expansion of CD4+ T cells in Sf mice was deter-
mined [35]. A rapid and selective expansion of the non-
clonotypic T cells was observed in Sf.OT-II mice.
Expanded populations express various V and V family
members of the non-Tg origin including T cells lacking the
Tg TCR and T cells expressing dual TCR with moderate
expression level of the Tg TCR. As clonotypic OT-II Tg T
cells are positively selected, the lack of their expansion
indicates that the positive selecting antigens are not suffi-
cient to induce expansion even in the absence of Treg.
This, in turn, indicates that the antigens responsible for
the Tconv expansion in Sf.OT-II mice must be host anti-
gens that include both self antigens as well as foreign anti-
gens that are steadily present in the host such as those
present in the air, foods, and microbiota but not rare anti-
gen such as ovalbumin even though the mice contain an
extremely high number of ovalbumin-specific Tg T cells.
To what extent are the self antigens and foreign antigens
contributing to the inflammation in individual organs in
Sf mice and their Rag1-/- recipients of transfer remains
unknown. With such a large repertoire, the identification
of the TCR specific targets associated with individual
organs may not be easily addressed for Sf mice.
A different case was reported in the Sf mice of Balb/c back-
ground [50]. Balb/c mice contain MMTV-encoded viral
super-antigens that are recognized by T cells expressing
V3, 5, 11, and 12. These T cells (except V11) are deleted
to a great extent by negative selection in the thymus
although the participation of these V family members in
the Treg population is high. However, more than 10-fold
increase in V3 or V5 T cells and a significant increase for
V11 and V12 T cells are found in the periphery of Balb/
c Sf but not normal Balb/c mice, thus providing direct evi-
dence that self antigens can modify V family distribution
pattern presumably by inducing proliferation and accu-
mulation of auto-reactive T cells and/or due to lack of
Treg-mediated, FasL-based killing of these cells [50]. It
will be interesting to determine how big is the repertoire
of these T cells and whether they affect the multi-organ
inflammation in an organ-specific manner in which the
organ strongly produces the MMTV antigens.
Concluding remark
By breeding and adoptive transfer experiments, Sf mice
are shown to contain a large repertoire of inflammation-
inducing T cells capable of inducing inflammation in a
large number of organs and tissues. Polyclonal Treg can
suppress the inflammation when tested, suggesting the
presence of an equally large repertoire of functional Treg.
An important issue is to determine whether inflammation
in individual organs is organ-specific. If so, what are the
organ-specific antigens? In this regard, Sf mice should be
useful to identify organ-specific Treg either by transferring
potential organ-specific Treg into Sf neonates or by co-
transfer with Sf lymph node cells into Rag1-/- recipients. Sf
mice are also useful to study the inflammation process
important to the inflammation of various organs. For
example, breeding specific an integrin or a chemokine
receptor mutant gene into Sf mice could address the
importance of the specific gene in the inflammation in
various organs at the same time.
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